Cadrenal Therapeutics
Cadrenal is a Florida-based clinical-stage biopharmaceutical firm that focuses on the research and development of novel therapies for the treatment of renal diseases and AFib.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Cadrenal Therapeutics Information
Geographic Data
Address: 822 A1A North
City: Ponte Vedra
State: FL
Zip: 32082
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$7M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cadrenal is a Florida-based clinical-stage biopharmaceutical firm that focuses on the research and development of novel therapies for the treatment of renal diseases and AFib.
Contact Phone:
+19043000701
Contact Email:
Cadrenal Therapeutics went public on 1/20/2023 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/20/2023
Ticker Symbol:
CVKD
IPO Price:
$5/share
Amount Raised:
$7M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
